13C Tracers for Glucose Degrading Pathway Discrimination in $Gluconobacter$ $oxydans$ 621H by Ostermann, Steffen et al.






13C Tracers for Glucose Degrading Pathway Discrimination in 
Gluconobacter oxydans 621H 
Steffen Ostermann, Janine Richhardt, Stephanie Bringer, Michael Bott, Wolfgang Wiechert, and 
Marco Oldiges * 
Institute of Bio- and Geosciences—IBG-1: Biotechnology, Leo-Brandt-Straße, 52428 Jülich, 
Germany; E-Mails: s.ostermann@fz-juelich.de (S.O.); j.richhardt@fz-juelich.de (J.R.);  
st.bringer-meyer@fz-juelich.de (S.B.); m.bott@fz-juelich.de (M.B.); w.wiechert@fz-juelich.de (W.W.) 
* Author to whom correspondence should be addressed; E-Mail: m.oldiges@fz-juelich.de;  
Tel.: +49-2461-61-3951; Fax: +49-2461-61-3870. 
Academic Editor:  Kazuyuki Shimizu 
Received: 10 July 2015 / Accepted: 24 August 2015 / Published: 2 September 2015 
 
Abstract: Gluconobacter oxydans 621H is used as an industrial production organism due to 
its exceptional ability to incompletely oxidize a great variety of carbohydrates in the 
periplasm. With glucose as the carbon source, up to 90% of the initial concentration is 
oxidized periplasmatically to gluconate and ketogluconates. Growth on glucose is biphasic 
and intracellular sugar catabolism proceeds via the Entner–Doudoroff pathway (EDP) and 
the pentose phosphate pathway (PPP). Here we studied the in vivo contributions of the two 
pathways to glucose catabolism on a microtiter scale. In our approach we applied specifically 
13C labeled glucose, whereby a labeling pattern in alanine was generated intracellularly. This 
method revealed a dynamic growth phase-dependent pathway activity with increased activity 
of EDP in the first and PPP in the second growth phase, respectively. Evidence for a growth 
phase-independent decarboxylation-carboxylation cycle around the pyruvate node was 
obtained from 13C fragmentation patterns of alanine. For the first time, down-scaled 
microtiter plate cultivation together with 13C-labeled substrate was applied for G. oxydans 
to elucidate pathway operation, exhibiting reasonable labeling costs and allowing for 
sufficient replicate experiments. 








The Gram-negative, strictly aerobic, rod-shaped acetic acid bacterium Gluconobacter oxydans has 
been used for stereo- and regioselective redox reactions in industrial processes for a long time [1–3]. 
Examples of the product spectrum are production of 6-amino-L-sorbose, a key intermediate for the 
synthesis of the diabetic drug miglitol, the tanning agent dihydroxyacetone from glycerol, and  
L-sorbose from sorbitol, the first step in the synthesis of vitamin C [4]. Despite its history as a production 
organism, there still remain a number of open questions about the growth and metabolism of this organism. 
Due to the absence of genes encoding for phosphofructokinase and phosphoenolpyruvate synthetase, 
the Embden–Meyerhoff–Parnas pathway (EMP) and gluconeogenesis are only partially functional [2]. 
Furthermore, the TCA cycle is truncated due to the absence of succinyl CoA synthetase and succinate 
dehydrogenase [2]. 
Genome sequence analysis revealed that G. oxydans has the complete gene composition to synthesize 
all proteinogenic amino acids [2]. Nevertheless, G. oxydans grows poorly on a minimal medium lacking 
proteinogenic amino acids [5–8]. This is in agreement with the fact that each amino acid itself can be 
omitted from the cultivation medium, but growth decreases stepwise with an increasing number of 
missing amino acids (own observation, unpublished). Hence, cultivation with a minimal medium 
containing L-glutamine as the sole amino acid and glucose as the carbon source led to a significantly 
reduced growth rate and final OD600 [8]. The reason for this behavior is not yet clear, but one can 
speculate that either the metabolic regulation of de novo amino acid biosynthesis is not efficient enough 
to compensate for missing amino acids or the organism might have a general limitation of energy or 
carbon precursors in the central metabolism. 
G. oxydans possesses two spatially separated ways for sugar metabolism. One is located in the 
periplasm and consists of membrane-bound dehydrogenases, which directly transfer electrons to the 
respiratory chain via ubiquinone (UQ10), and the other in the cytoplasm. The major fraction of carbon 
and energy source is first oxidized in the periplasm with further metabolization in the cytoplasm, either 
via the pentose phosphate pathway (PPP) or via the Entner–Doudoroff pathway (EDP). It was 
demonstrated that the PPP is of major importance for growth on mannitol and glucose [9,10]. Sugar 
degradation by use of the PPP is energetically more beneficial compared to degradation by  
EDP [10]. Gluconobacter oxydans shows a biphasic growth behavior on glucose [10]. In the first phase 
glucose is converted to gluconate by periplasmatic oxidation. In the second phase glucose is absent and 
growth depends on gluconate. The PPP is upregulated in the second growth phase, which was recently 
confirmed by transcriptomics and 13C metabolic flux analysis [11]. Experimental approaches with 
isotopically labeled tracers like 13C-labeled carbon sources are a powerful tool for elucidating the 
metabolic situation in vivo. However, the need for co-metabolization of substrate components like amino 
acids is barely understood in G. oxydans and remains a challenge for such approaches [12–14]. 
In this work we have used PPP and EDP deletion mutants [9] versus a G. oxydans wild-type strain to 
study the individual contribution of either pathway to carbon flux within the central metabolism of  
G. oxydans. Both pathways use a unique carbon transition pattern and finally end up in pyruvate, the 
precursor of e.g., alanine. Hence, alanine mirrors pyruvate 13C labeling information and can be easily 
extracted and measured by LC-MS/MS [15]. By determination of the positional labeling pattern in 
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alanine, PPP or EDP activity can be discriminated. Finally, the growth phase-dependent contribution of 
each pathway to the metabolism of the reference strain can be derived from these measurements. 
For the first time, a 13C-labeled substrate together with down-scaled microtiter plate cultivation was 
applied for G. oxydans to elucidate pathway operation, exhibiting reasonable labeling costs and allowing 
for sufficient replicate experiments. It was shown that with glucose the major degradation occurs via 
EDP, while the PPP becomes strongly upregulated after glucose depletion when gluconate is used as the 
substrate. The activation of the PPP is correlated with the secretion of acetate. Due to the lack of 
phosphofructokinase, fructose 6-phosphate formed in the PPP is isomerized to glucose 6-phosphate and 
enters the oxidative PPP again. Consequently, a partially cyclic flow of carbon through the PPP occurs 
and 1 mol glucose 6-phosphate is converted to 1 mol pyruvate and three mol carbon dioxide [11]. This 
may be a result of cellular energy demand. Furthermore, positional 13C labeling of alanine indicates an 
unusual carbon transition, fueling the hypothesis that there is an unexpected cyclic reaction sequence 
around the pyruvate node in G. oxydans. 
2. Results 
2.1. Cultivation of G. oxydans at a Small Scale 
The present study was conducted to clarify the participation of the two functional pathways for 
intracellular glucose metabolism, the EDP and the PPP. To this end, G. oxydans 621H Δupp as the 
parental reference strain containing both pathways and three mutant strains was examined [9].  
One strain was lacking the genes edd (6-phosphogluconate dehydratase, GOX0430) and eda  
(2-keto-3-deoxy-6-phosphogluconate aldolase, GOX0431), thus disabling the EDP. The other two 
mutant strains were lacking the gnd gene (6-phosphogluconate dehydrogenase, GOX1705), thus 
disabling the PPP, and one of these had in addition an inactive zwf gene (glucose 6-phosphate 
dehydrogenase, GOX0145), but no significant difference in the phenotypes of these two strains was 
observable under the experimental conditions. 
All four strains were cultivated in a microtiter plate (MTP) format in the Biolector® on a defined 
medium with 13C-labeled glucose as the carbon and energy source. To exclude an influence of the 13C 
labeling state of the substrate, all four strains were cultivated with differently labeled species of glucose 
in at least two biological and three technical replicates. The measurement of the growth phenotype (final 
pH and OD600) did not reveal any influence of the substrate labeling state, as shown in Figure 1. 
All strains showed a very similar final pH value of 4.5. This is in agreement with the fact that all 
strains had consumed the glucose completely (data not shown), which led to a drop in the pH due to the 
formation of gluconic and acetic acid. As already observed in bioreactor cultivations, the strains Δupp 
Δgnd and Δupp Δgnd-zwf*, both lacking the PPP, attained only half of the final OD600 of the strain 
lacking the EDP and the reference strain, giving a first hint of the importance of PPP in the second 
growth phase [10]. 




Figure 1. Offline measurement of final OD (white, dashed) and final pH value (grey) after 
24 h of cultivation for all combinations of mutant strain and 13C-labeled glucose. 
2.2. Transition of 13C Labeling from Glucose to Alanine by G. oxydans Metabolism 
Glucose is either oxidized by the membrane-bound glucose dehydrogenase (GOX0265, gdhM) to 
gluconate or taken up by the cells via an unknown transporter system, as the PTS system is considered 
to be inactive due to the absence of the required EIIB and EIIC subunits. Gluconate is taken up by the cells 
via a putative gluconate permease (GOX2188) [2]. Cytoplasmic catabolism of glucose can occur via 
glucose dehydrogenase (GOX2015, gdhS) or glucose kinases (GOX2419, glkA and GOX1182, glkB) [10]. 
For the labeling approach used in the present work, it is irrelevant whether single steps of the 
conversion from glucose to 6-phosphogluconate occur intra- or extracellularly, since the carbon 
backbone is not altered by this conversion. Intracellular gluconate can be converted to 5-ketogluconate 
by a gluconate-5-dehydrogenase (gno, GOX2187), or phosphorylated by a gluconate kinase (gnk, 
GOX1709) [2,16]. The metabolite 6-phosphogluconate (6-PG) exclusively serves as a precursor 
molecule for both intracellular glucose degradation pathways, i.e., PPP and EDP, and ends up in the 
common C3-molecule pyruvate. All carbon transition information was deduced with the Omix [17] 
software tool from the KEGG database [18]. In Figure 2, the schematic carbon transition is displayed. 
The six carbon atoms of 6-PG are converted by the EDP into two molecules. One molecule of 
pyruvate, containing C1–C3 of the 6-PG precursor, and one molecule of glyceraldehyde-3-phosphate 
(GAP), being composed of C4–C6 of 6-PG, are produced. In case of degradation by the PPP, only the 
last three carbon atoms C4–C6 of 6-PG are converted to GAP and finally to pyruvate. The C1 carbon of 
6-PG is directly decarboxylated by 6-phosphogluconate dehydrogenase (GND) to CO2. The remaining 
two carbon atoms, C2 and C3, are drained into biomass or turned into the C1 position of  
fructose-6-phosphate, which is again split off by GND in the next oxidative PPP cycle. Both pathways 
generate one molecule of GAP per glucose, which is finally converted to pyruvate, the primary precursor 
of alanine [19]. The GAP-pyruvate conversion occurs without change in the carbon backbone of the 
molecules and therefore without altering the 13C labeling information. 




Figure 2. Transition scheme of glucose via the pentose phosphate pathway (PPP) and the 
Entner–Doudoroff pathway (EDP). The circles indicate carbon atoms in the isotopic states 
12C (white) and 13C (black); depending on the substrate, the products may contain the 13C 
labeling (grey). The numbers of the carbon position in glucose is based on IUPAC nomenclature. 
The numbers in the remaining metabolites originate from the glucose carbon position. 
Alanine is synthesized by transamination of pyruvate without change in the carbon backbone and thus 
positional labeling information. The genome encodes two possible enzymes involved in pyruvate 
transamination, the serine-pyruvate transaminase EC 2.6.1.51 encoded by GOX1298 and another 
transaminase (EC.2.6.1.2) encoded by GOX0190. The second gene is annotated as aspartate 
aminotransferase but has 31% amino acid identity to an alanine transaminase in the strain Escherichia 
coli K-12 MG1655 (YP_190636.1) and contains conserved regions of the AAT_I superfamily. 
2.3. 13C labeling Experiments for Pathway Discrimination 
The schematic reactions from 6-phosphogluconate to alanine are presented in Figure 2, including the 
labeling pattern of alanine with respect to the used labeled glucose and the catabolic pathway. Labeling 
experiments were performed using four differently labeled variants of glucose, summarized in Table 1. 
The nomenclature of 13C labeling states of the metabolites is presented in Section 4.5. 
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12C control with unlabeled glucose. All four mutant strains showed the expected natural isotope 
abundance with comparable values for m.0 and m.1 respectively. This ratio was used for adjusting all 
labeling measurements for the alanine pattern of the preculture cells in the applied washout correction. 
Table 1. Mass isotopomer fractions in alanine of the four strains Δgnd, Δgnd zwf*,  
Δedd-eda, and Δupp cultivated with differently 13C labeled substrates. The isotopic state of 
alanine can be unlabeled (m.0), single (m.1), double (m.2), or triple (m.3) 13C labeled.  
All values were generated from at least two biological replicates with two technical replicates 
each. The values for (13C) samples represent six biological replicates each. All values are 
corrected for their inoculation labeling pattern. The nomenclature of the 13C labeling states 
of the metabolites is presented in Section 4.5. 
  Mass Spectrometry Signal Resp. Labeling State of Alanine 
Substrate Strain m.0 m.1 m.2 m.3 
12C control 
Δgnd 0.96 ± 0.001 0.04 ± 0.001 n.d. n.d. 
Δgnd-zwf* 0.96 ± 0.001 0.04 ± 0.001 n.d. n.d. 
Δedd-eda 0.96 ± 0.001 0.04 ± 0.001 n.d. n.d. 
Δupp 0.96 ± 0.001 0.04 ± 0.001 n.d. n.d. 
[13C] control 
Δgnd 0.37 ± 0.014 0.02 ± 0.001 0.07 ± 0.002 0.54 ± 0.015 
Δgnd-zwf* 0.37 ± 0.009 0.02 ± 0.001 0.08 ± 0.004 0.54 ± 0.008 
Δedd-eda 0.30 ± 0.013 0.03 ± 0.002 0.08 ± 0.003 0.59 ± 0.01 
Δupp 0.31 ± 0.01 0.02 ± 0.008 0.08 ± 0.005 0.59 ± 0.009 
[1-13C] 
Δgnd 0.51 ± 0.011 0.47 ± 0.011 0.01 ± 0.000 n.d. 
Δgnd-zwf* 0.50 ± 0.014 0.49 ± 0.014 0.02 ± 0.000 n.d. 
Δedd-eda 0.96 ± 0.000 0.04 ± 0.000 n.d. n.d. 
Δupp 0.76 ± 0.004 0.24 ± 0.003 0.01 ± 0.000 n.d. 
[1,2-13C] 
Δgnd 0.45 ± 0.016 0.09 ± 0.004 0.45 ± 0.013 0.01 ± 0.000 
Δgnd-zwf* 0.44 ± 0.031 0.09 ± 0.006 0.46 ± 0.024 0.01 ± 0.001 
Δedd-eda 0.95 ± 0.001 0.05 ± 0.001 n.d. n.d. 
Δupp 0.64 ± 0.006 0.13 ± 0.002 0.22 ± 0.004 0.01 ± 0.001 
[13C] control with fully labeled glucose. If there were no other pyruvate fueling reactions besides 
glucose degradation, the labeling state of alanine could be expected to be fully 13C labeled (m.3) in all 
mutant strains when fed with uniformly labeled [13C] glucose. However, an influx of 37% unlabeled 
alanine for the strains Δgnd and Δgnd–zwf* and 30% for the strains Δedd-eda and parent strain, respectively, 
was measured. This indicates that besides 13C glucose, unlabeled amino acids from the culture medium 
are also taken up and degraded to pyruvate, illustrating the challenge of cosubstrate metabolization. 
Since alanine was lacking in the culture medium, the fueling reactions for unlabeled pyruvate must 
depend on other amino acids, e.g., serine, which is converted to pyruvate by serine deaminase (GOX0794). 
The four strains can be grouped into absent PPP (Δgnd and Δgnd–zwf*) with 37% m.0 values, and 
active PPP (Δedd-eda and parent strain) with 7% lower m.0 values, respectively. Both groups show 
remarkably similar values within the error range. An absent PPP seemed to result in a higher demand for 
amino acid degradation, although the final OD was only 50% of the strains with active PPP (Figure 1). 
Reasons could be the lower energy yield of glucose degradation by the EDP instead of the PPP or the 
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gluconeogenetic formation of PPP intermediates for biomass formation and thus an increased amino  
acid catabolism. 
[1-13C]-labeled glucose. This substrate should result in 50/50 labeling distribution of unlabeled and 
single labeled alanine for the strains lacking PPP, and completely unlabeled alanine for the strain lacking 
EDP. For the PPP negative strains Δgnd and Δgnd-zwf*, the 13C-labeled C1 carbon from glucose is 
transferred into the C1 position of the first pyruvate. Due to the unlabeled second pyruvate generated 
from GAP, the observed results are close to the labeling ratio of 50/ 50 with a little more m.0 (m.0 = 
50.5, m.1 = 48). A more detailed picture for the single 13C labeling is given in Table 2.  
The m.1.1 lane indicates alanine molecules with a single 13C labeling at the carbon position C2 or C3. 
With 2%, this value is close to the natural labeling abundance. Consequently the m.1.0 isotopomer shows 
that 46% of all measured alanine molecules are specifically labeled at carbon position C1, as predicted 
by the labeling transition model. For the Δedd-eda mutant strain the 13C-labeled C1 carbon from glucose 
should be split off through decarboxylation by entering the PPP, resulting in alanine isotope enrichments 
comparable to the 12C control, which was achieved. The results for the Δupp strain (m.0 = 0.76, m.1 = 
0.24) are very interesting, since they are a superposition of both pathway phenotypes, clearly indicating 
that PPP and EDP are both involved in glucose degradation in the experiments. 
Table 2. Fragmentation pattern of alanine for (1-13C)- and (1,2-13C)-labeled glucose.  
The nomenclature of the 13C labeling states of the metabolites is presented in Section 4.5. 
  Mass Spectrometry Signal Resp. Labeling State of Alanine 
Substrate Strain m.0 m.1.0 m.1.1 m.2.1 m.2.2 m.3.2 
[1-13C] 
Δgnd 0.51 ± 0.011 0.45 ± 0.011 0.02 ± 0.000 0.01 ± 0.000 n.d. n.d. 
Δgnd-zwf* 0.50 ± 0.014 0.47 ± 0.014 0.02 ± 0.000 0.02 ± 0.000 n.d. n.d. 
Δedd-eda 0.96 ± 0.000 0.01 ± 0.000 0.03 ± 0.000 n.d. n.d. n.d. 
Δupp 0.76 ± 0.004 0.21 ± 0.004 0.03 ± 0.000 0.01 ± 0.000 n.d. n.d. 
[1,2-13C] 
Δgnd 0.45 ± 0.016 0.00 ± 0.002 0.08 ± 0.005 0.45 ± 0.013 n.d. 0.01 ± 0.000 
Δgnd-zwf* 0.44 ± 0.031 n.d. 0.08 ± 0.006 0.46 ± 0.024 n.d. 0.01 ± 0.001 
Δedd-eda 0.95 ± 0.001 0.01 ± 0.000 0.04 ± 0.001 n.d. n.d. n.d. 
Δupp 0.64 ± 0.006 0.05 ± 0.001 0.08 ± 0.001 0.21 ± 0.004 0.01 ± 0.000 0.01 ± 0.001 
[1,2-13C] labeled glucose. This substrate was expected to result in labeling patterns comparable to 
those for 13C1-labeled glucose due to the similarity in the carbon transition. The PPP negative strains 
Δgnd and Δgnd-zwf* showed with 45% m.0 and 45% m.2 the same ratio of unlabeled and double labeled 
alanine molecules as observed for 13C1-labeled glucose. However, 9% of single-labeled alanine was an 
unexpected finding. The more detailed fragmentation pattern (Table 2) indicated that nearly the whole 
signal stemmed from m.1.1. Hence, the 13C-labeled carbon atom is located at carbon position C2 or C3. 
An explanation could be a decarboxylation of the 13C-labeled C1 carbon atom of alanine or a precursor 
and a subsequent bonding of a naturally labeled carbon atom at this position. Such a potential reaction 
cycle would be concealed by the substrate [1-13C] glucose, since a 12C carbon exchange at position C1 
would result in unlabeled alanine. The Δedd-eda strain showed, with 95% m.0 and 5% m.1, respectively, 
high similarity to the expected natural labeling abundance. The results of the Δupp strain again represent 
a mixture of both pathway phenotypes concerning the m.0 and m.2 lane. This clearly points out that both 
pathways, PPP and EDP, were active in glucose catabolism. However, 13% signal for the m.1 lane was 
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again an unexpected finding and a strong hint that an essential reaction concerning the pyruvate node in 
G. oxydans still remains to be elucidated. 
The described results show that the mutant strains and substrate combinations used are suitable to 
prove participation of both pathways, PPP and EDP, in intracellular glucose degradation in the Δupp 
reference strain. Nevertheless, the control with uniformly labeled [13C] glucose indicated that besides 
glucose degradation additional pyruvate fueling reactions occur. In addition, the specific drain of GAP 
into biomass formation cannot be quantified with the setup used and thus it is difficult to determine a 
reliable pathway split ratio of the metabolic flux among PPP and EDP. 
2.4. Time Resolved 13C Labeling Experiments 
The results from labeling experiments clearly illustrated that PPP and EDP are both active during 
cultivation with glucose. Due to the biphasic growth behavior of G. oxydans, the question arose of 
whether PPP and EDP might have growth phase-specific functions. To gain insight into whether there 
was a growth phase-dependent pathway activity, the PPP negative strain Δgnd and the parent strain Δupp 
were cultivated with [1,2-13C] glucose for 24 h and sampled every 2 h. 
The offline measured values for OD, glucose consumption, and acetate secretion are displayed in 
Figure 3. In the first 6 h, glucose consumption and acetate formation were identical for both strains and 
likewise the growth rate. After 6 h of cultivation, the glucose consumption was dramatically reduced, 
matching a reported threshold of 6–8 mM glucose concentration to induce a glucose transport system in 
other organisms [20,21]. It took another 4 h to completely consume the glucose present in the  
culture medium. 
 
Figure 3. Growth (full lines) of Δupp (Δ, black) and Δgnd (o, red) strains. Glucose (dashed 
lines) and acetate (dotted lines) concentration in supernatant at a sequentially  
sampled cultivation. 
After 6 h, the Δgnd strain showed a drastic reduction of its growth rate and reached its final OD of 
1.1 ± 0.01 two hours later, whereas the parent strain exhibited only a slightly reduced growth rate after 
6 h and grew to an OD of 2.56 ± 0.01. Acetate excretion started after 4 h and the parent strain produced 
nearly a four-fold higher concentration after 24 h compared to the Δgnd strain. Concerning these data, it 
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can be assumed that with glucose falling below a certain concentration the metabolic activity was 
changing. The PPP-negative mutant Δgnd was no longer able to grow, so it can be concluded that PPP 
plays an essential role in the second growth phase. 
The specific labeling distribution in alanine, formed after degradation of [1,2-13C] glucose, is shown 
in Figure 4. For the PPP-negative Δgnd strain, with EDP as the exclusive catabolic pathway,  
a 50/50 mixture of m.0 and m.2 signal was expected due to the formation of unlabeled GAP,  
double-labeled pyruvate, and, subsequently, alanine. Two hours after inoculation, 66% of alanine m.2 
was found (Figure 4B). After an additional two hours, this was reduced to the expected theoretical value 
of 51%, then staying constant during the remaining cultivation. The signal for m.0 is a mixed signal from 
GAP and degraded unlabeled amino acids from the cultivation medium. It cannot be determined from 
the data whether the conversion rate of GAP to pyruvate or the uptake rate of precursors from the 
cultivation medium was changing. The observed reduction of growth rate after 6 h cannot be detected 
by the labeling state of alanine. Hence, a potential change of intracellular metabolism did not affect the 
alanine labeling state, i.e., the fueling and composition of the pyruvate pool. Identical growth rates for 
the PPP-negative strain Δgnd and the strain Δupp in the first 6 h show without a doubt that EDP pathway 
activity is sufficient for G. oxydans and PPP is not essential for growth on glucose in the first phase, as 
was also shown in bioreactor cultivations with higher substrate concentrations [10]. 
 
Figure 4. Mass isotopomer proportions of the 13C labeling states of alanine for (A) Δupp 
and (B) Δgnd mutant strains. The process time indicates the sampling points; the red line 
indicates the respective glucose concentration. The isotopic state of alanine can be unlabeled 
(m.0, black), single (m.1.0 blue dotted, m.1.1 blue dashed), double (m.2, grey), or triple (m.3, 
dark grey) 13C labeled. Mean values and standard deviations of at least two replicates are shown. 
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For the Δupp strain, the theoretical labeling values for either exclusive PPP or EDP pathway activity 
would be 0% and 50% (as observed for the Δgnd strain), respectively. As shown in Figure 4A,  
the labeling pattern can be separated into two phases. In the first 6 h, with glucose available the amount 
of m.2 labeled alanine increased by up to 33%. This can be directly correlated with increasing EDP 
activity. Although Olijve and Kok [8] described a complete repression of PPP under glucose-rich 
conditions, the labeling data clearly show a contribution of PPP to the glucose catabolism, otherwise 
higher m.2 mass isotopomer would have been present. Thus, it can be concluded that EDP and PPP 
pathways are both involved in glucose degradation in the first growth phase, confirming model-based 
results [11]. 
After 6 h, when glucose availability became limiting, the amount of m.2 labeling continuously 
decreased, down to 20% after 24 h (Figure 4A). This could be explained by an increasing degradation 
of unlabeled amino acids from the medium or a shift of the PPP/EDP split ratio towards PPP. The shift 
to PPP is coherent with the findings of Hanke et al. [11], showing a strong upregulation of PPP in the 
second growth phase on gluconate. Nevertheless, the data still indicate a relevant EDP contribution 
(otherwise m.2 would be diminished in that phase), but the PPP clearly is more important in this second 
growth phase on gluconate. This ultimate relevance of the PPP for the second growth phase is 
undoubtedly proven, since the PPP-negative Δgnd strains completely lacked a second growth phase and 
were not able to utilize gluconate for further biomass formation. 
For both strains (Δupp and Δgnd) a surprising signal for single-labeled alanine was detectable after 
degradation of [1,2-13C] glucose, which was not expected due to the network topology. In the Δgnd 
strain, single-labeled alanine is observed exclusively as an m.1.1 mass isotopomer, indicating 13C 
labeling at carbon position C2 or C3. Since the relative amount of 7 ± 1% single-labeled alanine did not 
change over the whole cultivation time, it seems to be a growth phase-independent reaction.  
As mentioned before, a specific C1 decarboxylation of double-labeled pyruvate with subsequent 
attachment of an unlabeled carbon monomer would be a possible explanation for these signals. 
The Δupp parent strain showed with 8.7 ± 0.7% a slightly increased amount of m.1.1. Furthermore, 
the mass isotopomer m.1.0 with 6.3 ± 0.4% was detectable in contrast to the Δgnd strain, indicating a 
specific 13C labeling at alanine carbon position C1. With regard to the network structure, this m.1.0 
isotopomer seems to involve a carboxylating reaction, i.e., 13CO2 could be ligated to an unlabeled  
C2 compound. The ratio between m.1.0 and m.1.1 over the cultivation time in the Δupp strain is 
predominantly constant, again indicating that this unknown metabolic process is not growth  
phase-dependent and might be at least partially PPP associated (m.1.0). 
3. Discussion 
In this work we addressed the question of whether labeling experiments with G. oxydans can be 
performed at a small scale to elucidate the participation of the two functional pathways for glucose 
metabolism, the EDP and the PPP. Apart from gaining knowledge on intracellular flux distribution, the 
aim of this work was to demonstrate the applicability of the novel microscale method for pathway 
analysis in G. oxydans. 
The labeling patterns shown indicate that the used network topology, especially for the PPP, EDP, 
and incomplete EMP, was correct, as nicely shown by the match between experimental labeling versus 
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theoretical prediction for the PPP and EDP in the reference experiments. The loss of labeling in the  
EDP-negative Δedd-eda strain when fed with [1-13C] or [1,2-13C] glucose matched 100% PPP pathway 
activity and was in agreement with the lack of 6-phosphofructokinase [2]. 
A control experiment with uniformly [13C]-labeled glucose showed a metabolic influx of naturally 
labeled substrates up to 37% into alanine for the strains lacking the PPP and 30% for the Δupp parent 
strain and the Δedd-eda mutant, demonstrating that supplemented amino acids from the medium are  
co-metabolized besides glucose. This illustrates the challenge of applying methods using isotopically 
labeled substrate if a suitable minimal culture medium is not available, especially for retrobiosynthetic 
approaches like this one. The amino acid uptake supports the observation of increasing maximal growth 
rate μmax and biomass yield dependent on the number of supplemented amino acids (unpublished data), 
pointing to the question of whether the provision of additional energy or the provision of additional 
carbon sources is responsible for the positive influence of amino acid supplementation on growth. 
In the presence of glucose, the periplasmatic oxidation from glucose to gluconate directly fuels the 
respiratory chain with electrons, allowing ATP formation by oxidative phosphorylation. The energy 
content of gluconate is less than that of glucose, since periplasmatic oxidation already cleaved hydrogen 
from the substrate. Hence, the energy and redox state of the gluconate substrate might not be sufficient 
to serve G. oxydans metabolism in the PPP negative Δgnd strain. An interesting difference between the 
usage of the PPP and the EDP is energetic efficiency. Under the assumption of complete degradation of 
glucose to acetate without side reactions, the conversion of 1 mol 6-phosphogluconate via the EDP yields 
2 mol acetate + 2 mol CO2 + 3 mol NAD(P)H + 2 mol ATP, while a cycling PPP degrades 1 mol  
6-phosphogluconate to 1 mol acetate + 4 mol CO2 + 6 mol NAD(P)H + 2 mol ATP [22]. An upregulation 
of PPP in the second growth phase would allow regeneration of 60% more reduced cofactors compared 
to the EDP. Hence, PPP is energetically more effective for metabolism, at the expense of higher loss of 
carbon dioxide. Energy supply seems to be a major regulatory motive of G. oxydans and potential 
insufficient energy supply of the PPP negative Δgnd mutant in the second growth phase on gluconate 
might be the reason for the absence of further growth. Our data comply with the results of a 
characterization of enzymes involved in the central metabolism of Gluconobacter oxydans, pointing to 
a major role of the pentose phosphate pathway in the intermediary metabolism of G. oxydans, while the 
Entner–Doudoroff pathway was found to contribute only to a minor extent during growth on gluconate 
in the second phase [23]. 
The periplasmatic conversion speed of glucose to gluconate is strongly reduced when glucose reaches 
a concentration of 5 mM, as reported by Olijve and Kok [8]. At the same time the growth rate is reduced 
and acetate secretion starts. Under these conditions the cells probably redirect the carbon flow from 
pyruvate to acetic acid, either due to a reduced precursor demand for biomass synthesis or to an increased 
cellular energy demand [24]. The oxidation of acetaldehyde, formed by pyruvate decarboxylase [25,26], 
delivers acetate and one reduced cofactor equivalent NAD(P)H, which could be the driving force for 
acetate formation in the second growth phase. Since the Δgnd strain still secretes acetate after  
having stopped biomass formation, the redox equivalents seem to be used for maintenance or other 
energy-consuming reactions. 
The labeling data generated with [1,2-13C] glucose revealed an unusual 13C labeling pattern in the 
m.1.0 and m.1.1 mass isotopomers. The stable amounts of m.1-labeled alanine for the continuously 
sampled strains Δupp and Δgnd show that the responsible reaction is growth phase independent and 
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continuously active at a constant rate. This gives rise to the conclusion about a potential futile cycle 
around the pyruvate node in G. oxydans. 
An explanation for the labeling pattern could be 1) decarboxylation of pyruvate carbon position C1 
with loss of one 13C, and 2) the addition of a naturally labeled single carbon at the remaining C2 molecule. 
Such a reaction would generate single-labeled alanine at carbon position C2 or C3, resulting in the 
observed m.1.1 alanine signal. In contrast to Δgnd mutant strains, the PPP-active Δupp strain additionally 
generated m.1.0-labeled alanine, indicating a specific C1 attachment of a 13C-labeled carbon at a 
naturally labeled C2 molecule. The first PPP-devoted reaction catalyzed by 6-phosphogluconate 
dehydrogenase specifically cleaves off the C1 atom of 6-PG, and in the case of [1-13C]- and  
[1,2-13C]-labeled glucose this results in 13CO2 formation, indicating that CO2 could be involved as the 
C1-unit in this transformation. This potential cycling is masked if 12C-, [13C]-, or [1-13C]-labeled glucose 
is used as the carbon source. When using [1-13C] glucose, the labeling information is located at carbon 
position C1. If the described reaction sequence occurs, the resulting molecule is masked as an unlabeled 
m.0 species due to the attachment of an unlabeled CO2 at position C1. This would lead to an elevated 
signal for the m.0 lane, which can indeed be observed for the strains Δgnd, Δgnd-zwf*, and Δupp  
(Tables 1 and 2). Consequently, for the [1-13C]-labeled substrate the ratio of unlabeled (m.0) to labeled 
(m.1, m.2, m.3) alanine is higher than the [1,2-13C]-labeled substrate. 
Several reactions, mainly around the pyruvate node, were checked as probable candidates for 
generating the observed labeling results. The side reaction of 2-keto-3-deoxy-6-phosphogluconate 
aldolase encoded by eda (GOX0430), i.e., decarboxylation of oxaloacetate to pyruvate, can be excluded 
since the resulting labeling transition does not match these results. The same holds true for the  
non-oxidative branch of the PPP catalyzed by transketolase and transaldolase, encoded by GOX1703 
and GOX1704. The decarboxylation reactions from pyruvate to acetyl-CoA or acetaldehyde generate a 
suitable reactive C2 molecule, but no reaction sequence back to pyruvate could be identified starting 
from acetyl-CoA. 
For acetaldehyde, a hypothetical reaction sequence explaining the observed labeling data was 
identified. The constitutively expressed pyruvate decarboxylase (pdc, GOX1081) converts 1 mol 
pyruvate to 1 mol acetaldehyde and 1 mol CO2 as main reaction, but is also able to condense 2 mol 
acetaldehyde to 1 mol acetoin under suitable reaction conditions [27], as shown in Figure 5. Next, a  
thus-far unspecified enzyme would have to carboxylate acetoin and simultaneously split the 
carboxylation product into one pyruvate and one acetaldehyde. Such a reaction sequence would allow 
the cell to get rid of toxic acetaldehyde and recover CO2. The resulting transition of 13C labeling would 
be a perfect match for the observed m.1.0 (Figure 5A) and m.1.1 (Figure 5B) mass isotopomers. 
The reverse reaction, i.e., the conversion of pyruvate and acetaldehyde to acetoin and carbon dioxide, 
has been described as a side activity of acetolactate synthase in Neurospora crassa by  
Kuwana et al. [26]. Nevertheless, this enzyme is not able to catalyze the opposite direction, i.e., the 
carboxylation of acetoin with carbon dioxide leading to pyruvate and acetaldehyde, since 
thermodynamics undoubtedly favor the decarboxylation. To conclude, the putative enzyme converting 
acetoin and carbon dioxide to pyruvate and acetaldehyde would require energy to shift the reaction 
equilibrium to the formation of pyruvate and acetaldehyde. 
Peters et al. [16] showed that a deletion of pdc leads to an export of pyruvate instead of acetate, 
indicating Pdc activity at least in the second growth phase. Furthermore, they observed an increased final 
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cell density in the Δpdc mutant compared to the Δupp strain. It was speculated that the absence of toxic 
acetaldehyde was the reason for this observation. It has been reported that G. oxydans has the potential 
to produce large quantities of aldehydes [2,28] and that a detoxification system is present, of which 
single enzymes are described [29–31]. Schweiger et al. [30] showed that GOX1122 is coding for an 
NADP-dependent acetaldehyde dehydrogenase and they speculate that G. oxydans may have some kind 
of carbon-recovering system. The proposed reaction sequence from two molecules of acetaldehyde via 
acetoin to one pyruvate and one acetaldehyde would perfectly fit the purpose of acetaldehyde 
detoxification as well as carbon recovery in the form of CO2 and also matches phenotype characteristics 
and observed labeling data. 
 
Figure 5. Scheme of a hypothetical reaction sequence from pyruvate via acetoin back to 
pyruvate, including the carbon transition. Atoms are labeled 13C (black) or 12C (white).  
The numbers originate from carbon position in the substrate glucose: (A) unlabeled 
precursors and 13C-labeled CO2 transformed to alanine generating m.1.0 signal;  
(B) double-labeled pyruvate originated from [1,2-13C]-labeled glucose transformed to 
alanine, generating an m.1.1 signal. 
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The labeling experiments showed an easy and fast evaluation method to estimate the participation of 
the two central metabolic pathways for intracellular glucose metabolism, the EDP and the PPP in  
G. oxydans. Measurement of final OD600 and pH after cultivation of G. oxydans in microtiter plates 
revealed small standard deviations of maximal 11%. Thus, growth of G. oxydans and the tested deletion 
mutants seems to be highly reproducible and labeling of glucose does not have an influence on growth. 
Cultivation in microtiter plates can be used for G. oxydans as a small-scale evaluation method, as it is 
used for other bacteria [32]. 
The easy sampling and biomass processing to obtain the labeling data from proteinogenic amino acids 
is a prerequisite for setting up automated sample treatment. With increasing availability of whole 
genomes and software-supported generation of metabolic carbon transition maps, this could become a 
valuable method for a fast and detailed screening to discriminate activity of central carbon metabolic or 
other pathways. The presented labeling data show that highly valuable flux estimations were obtained 
in a fast and reliable manner. In addition, new insight into the metabolism around the pyruvate node in 
G. oxydans was obtained, leading to a substantial hypothesis on the acetaldehyde detoxification in  
G. oxydans. 
4. Experimental Section 
4.1. Materials 
Chemicals were obtained from Sigma-Aldrich (Taufkirchen, Germany), Qiagen (Hilden, Germany), 
Merck (Darmstadt, Germany), and Roche Diagnostics (Mannheim, Germany). 13C-labeled glucose was 
obtained from Cambridge Isotope Laboratories (Andover, MA, USA) with a 13C isotopic purity of >99% 
per carbon atom. 
4.2. Bacterial Strains, Media, and Growth Conditions 
The bacterial strains used in this study are listed in Table 3. Gluconobacter oxydans ATCC 621H 
Δupp (ATCC 621H is identical to DSM2343), which lacks the upp gene for uracil 
phosphoribosyltransferase, was obtained from Armin Ehrenreich, Technical University of Munich, 
Germany [25]. In-frame deletion of the genes edd (GOX0431), eda (GOX0430), and gnd (GOX1705) 
was performed as described recently [9]. Precultures of G. oxydans strains were cultivated in a complex 
medium containing 5 g·L−1 yeast extract, 2.5 g·L−1 MgSO4 × 7 H20, 1 g·L−1 (NH4)2SO4, 1 g·L−1 KH2PO4, 
220 mM (4% w/v) mannitol, and 10 mM thymidine in baffled shake flasks at 30 °C and 140 rpm for 24 
h. The initial pH value of the medium was 6.0. As a precaution to prevent bacterial contamination, 
cefoxitin was added to the media at a concentration of 50 μg·mL−1 due to the natural resistance of  
G. oxydans. 
For labeling experiments, cells were cultivated in 48-well, flower-shaped microtiter plates (MTP) in 
a BioLector® (m2p-labs, Aachen, Germany). Each well was filled with 1 mL of a defined medium 
consisting of 1.98 g·L−1 (NH4)2SO4, 1 g·L−1 MgSO4 × 7 H2O, 3.48 g·L−1 KH2PO4, 10.5 g·L−1 sodium 
citrate, 0.5 g·L−1 FeSO4 × 7 H2O, 20 g·L−1 CaCl2, 50 mL·L−1 vitamin-Stock 100× (Sigma R 7256),  
50 μg·mL−1 cefoxitin, and 20 mL·L−1 of an amino acid stock containing the 14 proteinogenic amino 
acids histidine, cysteine, arginine, methionine, isoleucine, phenylalanine, glutamine, proline, glycine, 
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serine, threonine, lysine, asparagine, and glutamic acid, each at a concentration of 50 mM. The amino 
acids leucine, valine, and alanine were omitted to reduce interference with 13Clabeling signals for 
intracellular alanine. The initial pH was set to 6.0 using 10 M NaOH. To prevent the pH from dropping 
below 4, 150 mM piperazine-1,4-bispropanesulfonic acid was added as a buffer. As the primary carbon 
source, glucose was added at a concentration of 15 g·L−1 in these labeling states: naturally labeled, 
uniformly [13C]), [1-13C]-, and [1,2-13C]-labeled. 
Table 3. Strains used in this study. 
Strain (G. oxydans) Description Source 
Δupp Δgnd Δgnd derivative of G. oxydans 621H Δupp [9] 
(Deletion of GOX1705) 
Δupp Δgnd-zwf* Δgnd-zwf* derivative of G. oxydans 621H Δupp [9] 
(Deletion of GOX1705) with mutation in zwf (GOX0145) 
Δupp Δedd-eda Δedd-eda derivative of G. oxydans 621H Δupp [9] 
(Deletion of GOX0430 and GOX0431) 
Δupp Δupp derivative of G. oxydans 621H [16] 
(Deletion of GOX0327) 
Cells of the preculture were centrifuged for 3 min at 10,414 × g and 4 °C. The supernatant was 
discarded and the remaining cell pellet was washed twice with 5 mL 0.9% NaCl. The MTPs were 
inoculated to an OD600 of 0.10 ± 0.02 and incubated at 30 °C for 24 h. The shaking frequency was set at 
1000 rpm to avoid oxygen limitation, which had been checked in preliminary experiments with online 
pO2 determination by optode measurement. Evaporation is minimized by relative humidity of 100% in 
the incubation chamber and sealing of MTPs with gas-permeable membranes (m2p-labs). Each 
combination for substrate and mutant strain was cultivated in at least two biological and three technical 
replicates, whereof two were used for biomass hydrolysis and one for offline measurement of process data. 
4.3. Sample Treatment and Analysis 
The cells were harvested after 24 h from MTP and centrifuged for 10 min with 10,414 × g and the 
supernatant was stored for HPLC analysis or glucose assay. The unwashed cell pellet was suspended in 
200 μL of 6 M HCL and incubated at 110 °C for 24 h in airtight sealed reaction cups. After cooling down 
to room temperature, 1 mL of distilled H2O was added and the sample was filtered with 0.2 μm cellulose 
acetate membranes to remove cell debris. The clarified sample solution contained a mixture of 
proteinogenic amino acids and was used for LC-MS/MS analysis of L-alanine labeling pattern. 
Quantification of acetate was performed by HPLC using an Agilent 1100 system (Agilent, 
Waldbronn, Germany) with cation exchange chromatography (Organic Acid Resin 300 × 8,  
CS-Chromatographie Service, Langerwehe, Germany) and diode array detection at 215 nm. As solvent, 
0.005 M H2SO4 was used at a flow rate of 0.5 mL·min−1. The temperature was set to 40 °C and all 
samples were appropriately diluted to be in the linear range (0.5–5 mM) of the external calibration 
function. Glucose concentration was measured enzymatically with a standard protocol using 
hexokinase/glucose-6-phosphate dehydrogenase system with photometric detection of NADPH increase 
as described in [10]. 
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4.4. LC-MS/MS Measurements 
LC-MS/MS measurements were performed with an Agilent 1100 HPLC system (Agilent, Waldbronn, 
Germany) connected to an API 4000 triple quadrupole mass spectrometer (Ab Sciex Instruments, 
Darmstadt, Germany). For chromatographic separation, a Luna SCX column (Penomenex, 
Aschaffenburg, Germany) was used at 60 °C with a flow of 0.4 mL·min−1 [15]. For each sample 10 μL 
was injected. An isocratic elution with a solvent at pH 6 consisting of 5% acetic acid (in water) and  
15 mM ammonium acetate was used. The samples were diluted with pure MeOH by a factor of 2 prior 
to injection. 
4.5. 13C Labeling Nomenclature 
The index number at the carbon atom indicates its position in the carbon backbone based on IUPAC 
nomenclature i.e., naturally labeled, uniformly [13C], [1-13C]-, and [1,2-13C]-labeled. The selection and 
fragmentation of alanine in a triple quadrupole MS are shown in Figure 6. 
 
Figure 6. Selection and fragmentation of an ionized alanine molecule in the used triple 
quadrupole MS. The circled numbers indicate the carbon atoms of the alanine molecule 
derived from the carbon position of the substrate glucose; the red dots symbolize the inert 
gas particles (N2) for collision with the mother ion. 
In the first quadrupole, the so-called mother ions of alanine are selected, followed by fragmentation 
in the second quadrupole; finally, the resulting daughter fragment is selected in the third quadrupole and 
subsequently detected. With such a measurement of the mass-to-charge ratio (m/z) of the mother and 
daughter ions, the amount of 13C-labeled carbons in an alanine molecule can be determined. To 
distinguish between the different states of 13C labeling, the mass isotopomer nomenclature m.x.y is used, 
where x is the amount of 13C-labeled atoms in the mother ion and y in the daughter ion. Due to the 
described fragmentation, the m.0.0 lane represents alanine containing only 12C carbon, whereas m.3.2 
describes three 13C-labeled carbon atoms in an alanine molecule. For some labeling states, it is possible 
to gain additional information about the 13C labeling position in the carbon backbone from the available 
MS/MS fragmentation data. For example, an alanine molecule with 13C labeling at the specific carbon 
position C1 results in a m.1.0 signal, whereas 13C labeling at the position C2 or C3 results in an m.1.1 
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signal. To make the results shown in Table 1 more tangible, the labeling states were lumped together as 
unlabeled, single-, double-, and triple-labeled mass isotopomer fractions (m.0, m.1, m.2, and m.3). 
4.6. Washout Correction 
At the beginning of the 13C labeling phase, some residual 12C carbon species are still present in the 
cultivation, resulting from the inoculum cells. To compensate for that, a standard approach for washout 
correction was performed [33]. With the measured biomass concentration of each cultivation at the 
beginning and end of the experiments, it was possible to individually correct the labeling data based on 
the measured natural labeling pattern of alanine (m.0 = 95.9%, m.1 = 4.1%). 
5. Conclusions 
For the first time, a 13C-labeled substrate together with down-scaled microtiter plate cultivation was 
applied for G. oxydans to elucidate pathway operation, exhibiting reasonable labeling costs and allowing 
for sufficient replicate experiments. The in vivo contribution of the EDP and PPP pathway to glucose 
catabolism was investigated. In our approach we applied specifically 13C labeled glucose, whereby a 
labeling pattern in alanine was generated intracellularly revealing a dynamic growth phase-dependent 
pathway switch. Increased activity of EDP was observed in the first phase with glucose excess, while 
PPP operation was observed in the second growth phase metabolizing the intermediary formed 
gluconate. This pathway switch may be a result of cellular energy demand, since PPP provides more 
efficient energy regeneration. Furthermore, positional 13C labeling of alanine indicates an unusual carbon 
transition, fueling the hypothesis that there is an unexpected cyclic reaction sequence around the 
pyruvate node in G. oxydans. Evidence for a growth phase-independent decarboxylation-carboxylation 
cycle around the pyruvate node was obtained from 13C fragmentation patterns of alanine. The proposed 
reaction sequence converts acetaldehyde into pyruvate and might have function to decrease toxic side 
effects of acetaldehyde in the metabolism of G. oxydans. 
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